Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13002
Country/Region: Uganda
Year: 2015
Main Partner: United Nations High Commissioner for Refugees
Main Partner Program: NA
Organizational Type: Multi-lateral Agency
Funding Agency: enumerations.State/PRM
Total Funding: $324,721 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $75,025
Care: Orphans and Vulnerable Children (HKID) $46,972
Care: TB/HIV (HVTB) $14,615
Care: Pediatric Care and Support (PDCS) $26,361
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $18,782
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $33,332
Treatment: Adult Treatment (HTXS) $102,799
Treatment: Pediatric Treatment (PDTX) $6,835
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 49
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 881
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 5
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 89
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 95
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 1,721
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 6
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 106
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 2,797
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 155
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 2,797
CARE_NEW Aggregated Age/sex: 15+ Female 2016 205
CARE_NEW Aggregated Age/sex: 15+ Male 2016 111
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 339
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 339
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 339
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 34
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 906
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 26
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 683
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 257
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 6,882
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 186
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 4,964
HTS_TST By Test Result: Negative 2016 488
HTS_TST By Test Result: Negative 2016 13,031
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 503
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 13,435
HTS_TST Sum of Aggregated Age/Sex <15 2016 60
HTS_TST Sum of Aggregated Age/Sex <15 2016 1,589
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 443
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 11,846
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 503
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 13,435
HTS_TST Sum of Test Result disaggregates 2016 503
HTS_TST Sum of Test Result disaggregates 2016 13,435
HTS_TST_POS By Test Result: Positive 2016 15
HTS_TST_POS By Test Result: Positive 2016 404
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2016 526
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2016 1,023
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 366
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 366
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 262
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 104
PMTCT_ARV Sum of New and Current disaggregates 2016 366
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 29
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 293
PMTCT_EID Sum of Infant Age disaggregates 2016 293
PMTCT_STAT By: Known positives at entry 2016 262
PMTCT_STAT By: Number of new positives identified 2016 104
PMTCT_STAT Number of new ANC and L&D clients 2016 6,603
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 6,273
PMTCT_STAT Sum of Positives Status disaggregates 2016 366
PP_PREV Age/sex: 10-14 Female 2016 233
PP_PREV Age/sex: 10-14 Male 2016 180
PP_PREV Age/sex: 15-19 Female 2016 445
PP_PREV Age/sex: 15-19 Male 2016 333
PP_PREV Age/sex: 20-24 Female 2016 659
PP_PREV Age/sex: 20-24 Male 2016 363
PP_PREV Age/sex: 25-49 Female 2016 947
PP_PREV Age/sex: 25-49 Male 2016 651
PP_PREV Age/sex: 50+ Female 2016 63
PP_PREV Age/sex: 50+ Male 2016 57
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 3,931
PP_PREV Sum of Age/Sex disaggregates 2016 3,931
TB_ART Aggregated Age: <15 2016 3
TB_ART Aggregated Age: 15+ 2016 35
TB_ART Female 2016 25
TB_ART Known HIV-positive 2016 17
TB_ART Male 2016 13
TB_ART Sum of Aggregated Age disaggregates 2016 38
TB_ART Sum of Sex disaggregates 2016 38
TB_ART Sum of Test Status disaggregates 2016 17
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 46
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 38
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 196
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 2,601
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 2,797
TB_SCREEN Sex: Female 2016 1,827
TB_SCREEN Sex: Male 2016 970
TB_SCREEN Sum of Aggregated Age disaggregates 2016 2,797
TB_SCREEN Sum of Sex disaggregates 2016 2,797
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 2,797
TX_CURR Aggregated Age/Sex: 15+ Female 2016 747
TX_CURR Aggregated Age/Sex: 15+ Male 2016 89
TX_CURR Aggregated Age/Sex: 15+ Male 2016 1,623
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 2,558
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 10
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 129
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 2,370
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 129
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 2,370
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 174
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 369
TX_NEW Breastfeeding status 2016 2
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 566
TX_NEW Pregnancy status 2016 104
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 543
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 491
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 578